Ponatinib-D8 is a deuterium labeled Ponatinib. Ponatinib (T2372) is an orally active inhibitor of multi-targeted kinase (Abl, PDGFRalpha, VEGFR2, FGFR1, and Src with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM, respectively).
Molecular Weight:
540.61
CAS Number:
[1562993-37-6]
Formula:
C29H27F3N6O
Target:
Bcr-Abl|||Src|||VEGFR|||Autophagy|||FGFR|||PDGFR
T12521
* VAT and and shipping costs not included. Errors and price changes excepted